Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00406952
Status:
COMPLETED
Last Update Posted:
2008-08-21
First Post:
2006-11-30
Brief Title:
Study for Evaluating Different Methods of Measuring Depression Treatment Response
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Phase 4 Randomized Double-Blind Placebo Controlled Methodology Study to Evaluate the Time of Onset of AntiDepressant Response in Subjects With Major Depressive Disorder
Status:
COMPLETED
Status Verified Date:
2008-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Purpose of the study is to evaluate use of electronic diaries and voice acoustics for use in future depression clinical trial Focus is on increased precision of measurement
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None